3 days popular7 days popular1 month popular3 months popular

ORBERA Intragastric Balloon US pivotal trial results presented

Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, has announced the presentation of results from the ORBERA™ Pivotal Trial at this year’s Digestive Disease Week (DDW) conference. The study showed that ORBERA™ Intragastric Balloon users lost significantly more weight than the control group, leading to significant improvement [...]

Clinical trial examines safety, effectiveness of drug to treat binge eating disorder

At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a public health problem associated symptoms of mental illness and obesity and for which there are no approved medications, according to a study published online [...]

You can overcome your obsessions with internet treatment: no talking, just writing

A group of German investigators reports on the affects of internet based treatment on obsessive symptoms in Psychotherapy and Psychosomatics. Many patients with obsessive-compulsive disorder (OCD) do not receive first-line treatment according to the current guidelines (cognitive behavioral therapy with exposure and response prevention, CBT with ERP) due to barriers to treatment. Internet-based therapy is [...]

Novel 3D Stent Demonstrates Safety And Efficacy In Treatment Of PAD

New data presented at the annual VIVA (Vascular InterVentional Advances) conference has shown that a stent with unique three-dimensional geometry, BioMimics 3D™, demonstrated an excellent safety profile and promising clinical performance at both six and twelve months in the treatment of patients with peripheral arterial disease (PAD) undergoing femoropopliteal artery intervention. The MIMICS study is [...]

In Children Treated With Peginterferon Alpha For Hepatitis C, There Are Height, Weight And BMI Changes

Follow-up research from the Pediatric Study of Hepatitis C (PEDS-C) trial reveals that children treated with peginterferon alpha (pegIFNα) for hepatitis C (HCV) display significant changes in height, weight, body mass index (BMI), and body composition. Results appearing in the August issue of Hepatology, a journal of the American Association for the Study of Liver [...]